Cargando…
What Matters the Most for Hormonal Therapy in West Syndrome: Drug, Dosage, or Duration?
Autores principales: | Sahu, Jitendra Kumar, Madaan, Priyanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997786/ https://www.ncbi.nlm.nih.gov/pubmed/33772432 http://dx.doi.org/10.1007/s12098-021-03747-z |
Ejemplares similares
-
Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group
por: Sahu, Jitendra Kumar, et al.
Publicado: (2020) -
Epilepsy and Neurodevelopmental Outcomes in a Cohort of West Syndrome Beyond Two Years of Age
por: Aramanadka, Reshma, et al.
Publicado: (2021) -
COVID-19 in Children with West Syndrome: An Ambispective Study
por: Madaan, Priyanka, et al.
Publicado: (2022) -
Financial Burden in Families of Children with West Syndrome
por: Raithatha, Dhvani, et al.
Publicado: (2021) -
Oral Prednisolone Versus Dexamethasone for the Treatment of Infantile Epileptic Spasms Syndrome: Current Status and Way Forward
por: Sahu, Jitendra Kumar, et al.
Publicado: (2022)